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Copyright © 2009 AHC The development of mouse submandibular gland (SMG) begins at embryonic day 11.5–12
(E11.5–12), during which successive rounds of epithelial clefting and branching create com-
plex epithelial tree-like structures. Homeobox genes regulate place-dependent morpho-
genesis, including epithelial-mesenchymal interactions, and control the expression patterns
of signaling molecules. The Barx2 containing Homeobox exerts several key roles in develop-
ment. Some studies have shown that the Barx2 plays important roles in the epithelial-
mesenchymal interactions of organogenesis. However, the mechanisms of Barx2 associated
with the development of SMG are obscure. In this study, we demonstrated for the first time
the exact spatial and temporal Barx2 expression pattern in SMG epithelial tissue during de-
velopment using immunohistochemical staining and Real-Time quantitative PCR. Barx2 was
expressed in the nucleus of the epithelial cells located in the proliferative and differentiative
regions of the developing SMG during the early development stages (E11.5–E13.5). After
the E14.5-time period, the expression gradually decreased, and at E16.5, expression mostly
disappeared despite the fact that evidence of cytodifferentiation, such as the appearance of
proacinar cells, distinct lumen formation, and secretory products, was beginning to be ob-
served. Results of Real-Time PCR demonstrated that the amount of Barx2 mRNA expres-
sion in SMG was maximal on E14.5, and gradually decreased by E18.5. These results indi-
cate that Barx2 is associated with early stage epithelial tissue development, and can be a
useful epithelial marker of the SMG during early developmental stages.
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I. Introduction
Around embryonic day 11 (E11), embryonic mouse
submandibular gland (SMG) morphogenesis is initiated with
the thickening of mandibular arch oral epithelium. This
thickened epithelium grows down into the first brachial
(mandibular) arch mesenchyme, which is derived from the
cranial neural crest, to form the initial SMG bud. With con-
tinued epithelial proliferation and successive rounds of cleft
formation, duct elongation, and lumen formation, the SMG
primordium becomes more complex and develops a charac-
teristic three-dimensional, tree-like structure [7]. This devel-
opmental system is called branching morphogenesis and is
observed in many organs, such as the mammary glands,
lungs, pancreas, and the kidneys. Some studies have re-
vealed that branching morphogenesis is dependent on epi-
thelial-mesenchymal interactions [4], and that this inter-
action is regulated by many different signaling molecules,
such as bone morphogenetic proteins (BMPs) [6, 13], trans-
forming growth factors (TGFs) [3, 9, 12], fibroblast growth
factors [13, 15, 16, 31], epidermal growth factor (EGF) [9,
20, 21], hepatocyte growth factor (HGF) [8], sonic hedgehog
(Shh) [14], hormones [9, 11], and extracellular matrix
(ECM) [23]. Homeobox genes are thought to be transcrip-
tion factors that control the activity of other genes. In manyNaka and Yokose 48
organs, as well as the SMG [11, 22], the expression of these
genes has been well investigated [19, 29]. To date, several
homeobox genes including Six-1 [22], Pitx-1 [32], Pax-6
[13] and Msx-2 [11] have been shown to be differentially
and spatially expressed during embryonic development of
the SMG. However, not much is known about which mole-
cules are regulated by the products of these genes. Other
homeobox genes have been implicated in the control of the
expression of cell adhesion molecules [17, 34]. A vertebrate
homolog of the Drosophila Bar homeobox gene, mouse
Barx2, was isolated when various factors regulating the gene
for the cell adhesion molecules NCAM-L1 were screened
[18]. Barx2 appears to be able to both activate and repress
the NCAM-L1 promoter. In mouse embryogenesis, Barx2 is
expressed in the central and peripheral nervous system and
the ectodermal lining of craniofacial tissues, regions that
express NCAM-L1 and another cell adhesion molecule,
Ng-CAM [18]. However, the precise location of Barx2 in
the complex SMG tissue was not identified to date.
This study determined whether Barx2 exerts an effect
during SMG development. Using immunohistochemistry
the spatiotemporal distribution of Barx2 during the various
stages of SMG development was investigated.
II. Materials and Methods
Sample preparation
All animal experiments were performed according to
the guidelines for the care and use of animal issued by Ohu
University. Timed-pregnant female mice (strain ICR) were
purchased from Clea Japan (Tokyo, Japan). The plug day
was considered to be the day of gestation initiation. Pregnant
mice were anesthetized with diethyl ether and sacrificed by
cervical dislocation on days 11.5, 12.5, 13.5, 14.5, 16.5, and
18.5 of gestation (E11.5, 12.5, 13.5, 14.5, 16.5, and 18.5,
respectively). Embryos were dissected in cold phosphate-
buffered-saline (PBS, Takara Bio Inc., Shiga, Japan) and
were used for the immunohistochemical analysis. Mouse
embryos at E11.5–13.5 were fixed in 10% phosphate-
buffered neutral formalin (pH 7.4) (Wako Pure Chemical
Industries, Ltd., Osaka, Japan), dehydrated in an ethanol
(Wako Pure Chemical Industries, Ltd., Osaka, Japan) series,
washed in xylene, and then embedded in paraffin. Embryos
at E14.5–18.5 were decalcified in 0.5 mol/l EDTA (pH
7.5) (Wako Pure Chemical Industries) for 5 days at 4°C
prior to ethanol dehydration.
Immunohistochemistry
Immunohistochemical staining was performed as de-
scribed previously [28].
Rabbit polyclonal antibody to mouse Barx2 and
NCAM-L1 was obtained from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA, USA). These antibodies were used in
the immunohistochemical analysis to detect Barx2 or
NCAM-L1, respectively.
Some sections were stained with hematoxylin and eosin
(H&E), and the other sections were stained using immuno-
histochemical techniques to identify Barx2. Tissue sections
(4–5-μm-thick) were mounted on poly-L-lysine coated
slides. For staining, the slides were dewaxed with xylene, re-
hydrated with descending grades of ethanol, and rinsed with
Tris-Buffered-Saline (TBS, Takara Bio Inc.). After washing
with TBS, endogenous peroxidase was blocked by 0.3% hy-
drogen peroxide at room temperature for 10 min. Then, the
slides were washed with TBS and treated with 0.1% trypsin
solution (Nichirei Biosciences Inc, Tokyo, Japan) for 10
min. Subsequently, all slides were washed with TBS and
blocked using endogenous mouse immunoglobulin for 30
min at 4°C with goat serum. After washing with TBS, the
primary antibodies were diluted, and the slides were incubat-
ed overnight at 4°C. Negative control slides were incubated
in diluent buffer alone. The slides were then washed with
TBS and incubated for 10 min at room temperature with
biotinylated goat anti-rabbit secondary antibody (Histofine
SAB-PO(R) kit; Nichirei Biosciences Inc.). After washing
with TBS, the sections were incubated with peroxide-
conjugated streptavidin for 5 min at room temperature
(Nichirei Biosciences Inc.). After washing with TBS, the
DAB substrate kit (Nichirei Biosciences Inc.) was applied
to the slides for 6 min at room temperature. Next, all of the
slides were dehydrated and mounted. The experiments were
repeated at least 5 times to negate sex differences between
the specimens.
RNA isolation and Real-Time PCR
Total RNA was extracted from E12.5~18.5 SMG using
EASYPrep RNAKit (Takara Bio Inc.), and treated with
DNase 1 (Toyobo Co., LTD. Osaka, Japan). First-stand
cDNA was synthesized from total RNA (400 ng) using RT-
PCR kit (Takara Bio Inc.) and random primers. Subsequent-
ly 1 μg of cDNA was used as a template for the second step
of Real-Time quantitative PCR (RT-qPCR). Primers was
used at 5 μM with 12.5 μl of SYBR Green Premix (Takara
Bio Inc.) in a final volume of 25 μl.
SYBR Green PCR amplification and real-time fluores-
cence detection were performed using the Smart Cycler II
System (Takara Bio Inc.). Rapid PCR cycling conditions
were as follows: 95°C for 10 seconds (denaturation), fol-
lowed by 45 cycles at 95°C for 5 seconds and 60°C for 20
seconds (annealing/extension). The primer sequencese were
as follows: β-actin, 5'-ATT CCG ACA GGA TGC GCA
GA-3' and 5'-GAG TAC TTG CGC TCA GGA GGA-3';
Barx2, 5'-CAG AAG TCG CAC CAT CTT CAC C-3' and
5'-CTT CAC TTG CAG CTG AGT GAG TCC-3'. Measure-
ments were taken at the 60°C extension step in each cycle,
and the second-derivative method was used to calculate the
threshold cycle. Melt curve analysis showed a single sharp
peak for all samples. Target gene expression level was
normalized to beta-actin expression in each sample. Each
PCR product was analyzed by 3% agarose gel electrophore-
sis, and ethidium bromide-stained PCR products were
evaluated.Expression of Barx2 in Mouse Embryo SMG 49
III. Results
Barx2 localization in SMG
At early E11.5, the oral epithelium proliferates to form
a thickened epithelium. This thickened epithelium grows
down into the underlying mesenchyme, which is derived
from cranial neural crest cells, and forms a complex SMG
structure (Fig. 1A and B). The expression of Barx2 was ob-
served in the nucleus of this thickened oral epithelium. Pos-
itive staining was not observed in the other areas of the oral
epithelium (Fig. 1C and D). During the late E11.5 stage, the
thickened epithelium had deeply invaded into a condensed
mesenchyme and solid epithelial stalk, at this time, a termi-
nal bulb was first observed (Fig. 1E and F). The positive
staining of Barx2 was observed in the nucleus of the oral
epithelium around the ductal foramen, epithelial stalk, and
epithelial bud (Fig. 1G and H). At E12.5, the epithelial
stalk and terminal bulb were clearly observed, and the initial
formation of the sublingual gland was observed next to the
SMG primordia (Fig. 1I and J). The expression of Barx2 was
observed clearly throughout SMG epithelial components,
such as the stalk and the terminal-bulb (Fig. 1K and L). At
E13.5, the solid cord of epithelium elongated and formed the
presumptive duct and terminal buds (Fig. 2A). The expres-
sion of Barx2 in the nucleus of the branched epithelium of
SMG was still high at E13.5 (Fig. 2B). At E14.5, an in-
creased number of epithelial lobules and complex presump-
Fig. 1. Immunohistochemical staining for Barx2 expression during embryonic submandibular gland (SMG) development. A, B, E, F, I, and J:
Hematoxylin and eosin (H&E) staining during SMG development. C, D, G, H, K, and L: Barx2 expression in the developing SMG. B, D, F, H,
J, and L: Higher magnification of the boxed section in A, C, E, G, I, and K. A–D: At early E11.5, Barx2 is primarily found in the thickening
oral epithelium. E–H: At late E11.5, Barx2 is primarily immunolocalized in the oral epithelium, the epithelial stalk, and the epithelial bulb. I–L:
At E12.5, Barx2 is immunolocalized in the epithelium stalk and the end-bulb. Bar=100 µm. TG: tongue. *: mesenchymal tissue.
Fig. 2. Immunohistochemical analysis of Barx2 expression during
embryonic SMG development. A and C: H&E staining of the
developing SMG. B and D: Barx2 expression in the developing
SMG. A and B: At E13.5, Barx2 is seen throughout the branching
epithelia. C and D: At E14.5, Barx2 is found only in some epithe-
lial buds and ductal epithelia. Bar=200 µm. *: mesenchymal tissue.Naka and Yokose 50
tive ducts that consisted of multilayered epithelial cells were
observed. Lamina formation was clearly observed into the
presumptive ducts (Fig. 2C). The expression of Barx2
gradually decreased in all epithelial structures overtime
(Fig. 2D). At E16.5, the duct system was clearly identified,
and the terminal bud lumina had increased in size. The initial
stages of glandular cytodifferentiation into serous acina and
mucous acina were observed (Fig. 3A). The expression of
Barx2 was barely detectable at this stage (Fig. 3B). Continu-
ing in this vein, the expression of Barx2 at E18.5 was nega-
tive (Fig. 3C and D). Control slides that were incubated in
the absence of primary antibody were found to have no spe-
cific staining (data not shown).
Real-time quantative PCR
In order to confirm the expression of Barx2 in the
developing SMG, we used RT-qPCR to evaluate the
expression level of Barx2. The expression level of Barx2
was higher in the E14.5 and gradually decreased until
E18.5 (Fig. 4).
NCAM-L1 lodcalization in SMG
At E12.5, the expression of NCAM-L1 was localized in
the epithelial tissues at cell-cell surface (Fig. 5B). At E14.5,
NCAM-L1 was expressed in the epithelium at cell-cell sur-
face of the branched epithelium (Fig. 5D). The expression of
NCAM-L1 at E18.5 was observed but decreased in the epi-
thelial tissues (Fig. 5F).
IV. Discussion
In this study, the expression of Barx2, one of the
homeobox genes, during the development of fetal mouse
SMG was investigated. The results of the present study
show that Barx2 is expressed in the epithelium of the SMG
during the early developmental stage. These results suggest
that Barx2 may be a critical factor in the development of
SMG. To the best of our knowledge, this is the first report
that shows the exact spatial and temporal immunohisto-
chemical expression of Barx2 during SMG development.
Homeobox genes play important roles in the organo-
genesis and the morphogenesis that occurs during vertebrate
Fig. 3. Immunohistochemical analysis of Barx2 expression during embryonic SMG development. A and C: H&E staining of the developing
SMG. B and D: Barx2 expression in the developing SMG. A and B: At E16.5, no expression of Barx2 is found. C and D: At E18.5, no expres-
sion of Barx2 is found. Bar=200 µm. SMG: submandibular gland. SLG: sublingual gland.
Fig. 4. RT-qPCR analysis of Barx2 expression during fetal mouse
SMG development. Barx2 expression levels are higher at E14.5
and as developmental stages are progressed, the expression was
decreased until E18.5.Expression of Barx2 in Mouse Embryo SMG 51
development [19, 22]. Previous studies dealing with SMG
development have revealed that the knockout of Six1 or
Pax6 results in SMG malformation [13, 16] and that the
knockout of Pitx1 induces a lack of SMG formation [32]. A
study using in situ hybridization noted that Msx2, Barx1 and
Barx2 are involved in SMG development [11, 27, 33]. Espe-
cially, Barx1 was observed in the mesenchymal tissue of
the developing SMG between E11.5 and E15.5. After the
period, the expression mostly disappeared [33]. Barx1 and
Barx2 both belong to the Bar class homeobox genes, and
they have a complementary expression pattern during the
development of craniofacial structures [18]. These studies
support our findings that Barx2 is intimately correlated with
SMG development.
In this report, using immunhistochemical techniques,
the expression of Barx2 was observed mainly in the nucleus
of the epithelial cells that form the buds, stalk, and ducts dur-
ing E11.5–14.5, which is considered the early developmen-
tal stage. After this time period, the expression of Barx2 was
reduced, and its expression was barely detected until E16.5,
at which time the epithelial cells began to express secretory
gland characteristics [10]. We also used RT-qPCR tech-
niques to confirm the expression of Barx2 in the developing
SMG and found that the expression of Barx2 correlated with
the results of immunohistochemical staining. These results
suggest that Barx2 may be required for the initiation of
epithelial thickening, initial bud formation, and the earliest
epithelial branching, but that it may not be involved in the
epithelial differentiation that occurs during the late stage.
It has been demonstrated that branching morphogenesis is
mediated by an epithelial-mesenchymal interaction con-
trolled by certain growth factors, homeobox genes and cell
adhesive molecules. However, the role of Barx2 and of
the signaling cascades that are downstream of the Barx2
remains unclear with respect to SMG development. To date,
there is evidence that Barx2 is a protein that binds to a
regulatory element that is common to the genes related to
two neural cell adhesion molecules (NCAMs), Ng-CAM
and NCAM-L1 [18, 30]. NCAM mediates cell-cell adhesion
not only in the neuronal system but also in a variety of em-
bryonic tissues, such as the teeth, kidneys, pancreas, and hair
follicles [1, 2, 5, 24, 26]. These organs, as well as the SMG,
are structured by epithelial-mesenchymal interaction. In
this paper, we also observed NCAM-L1 expression in the
SMG epithelial tissues. This suggests that Barx2 may con-
trol the morphogenesis of the early developmental stage
of SMG by controlling the expression of cell adhesion mole-
cules such as NCAM and NCAM-L1 on the epithelial side
[25, 33].
In conclusion, we demonstrated that the expression of
Barx2 was restricted to the epithelial cells during the early
developmental stage of the fetal mouse SMG (Fig. 6). This
Fig. 5. Immunohistochemical analysis of NCAM-L1 expression during embryonic SMG development. A, C and E: H&E staining of the devel-
oping SMG. B, D and F: NCAM-L1 expression in the developing SMG. B: At E12.5, NCAM-L1 is immunolocalized in the cell-cell surface of
the epithelium stalk and the end-bulb. D: At E14.5, NCAM-L1 is seen throughout the cell-cell surface of the branching epithelia. F: At E18.5,
weak expression of NCAM-L1 is found in the epithelial tissues. Bar=100 µm.
Fig. 6. Summary of the changes in the expression of Barx2 during
fetal mouse SMG development. A high level of Barx2 binding was
observed in the developing fetal mouse SMG epithelial cells
between E11.5 and E13.5. The expression of Barx2 gradually
decreased and almost completely disappeared by E16.5.Naka and Yokose 52
suggests that the homeobox gene, Barx2, plays physiologi-
cal roles in developing SMG development. These data con-
tribute to the fundamental studies of SMG development and
morphogenesis.
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